AMYLOID CARDIOMYOPATHY
Clinical trials for AMYLOID CARDIOMYOPATHY explained in plain language.
Never miss a new study
Get alerted when new AMYLOID CARDIOMYOPATHY trials appear
Sign up with your email to follow new studies for AMYLOID CARDIOMYOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a diabetes drug help hearts stiffened by amyloid?
Disease control Recruiting nowThis study tests whether Enavogliflozin, a drug used for diabetes, can help people with amyloid cardiomyopathy, a condition where abnormal proteins build up in the heart. About 68 adults with heart failure symptoms will take the drug or a placebo for 12 weeks, then switch. The ma…
Matched conditions: AMYLOID CARDIOMYOPATHY
Phase: PHASE4 • Sponsor: Seoul St. Mary's Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug aims to stop rare genetic disease before it strikes
Prevention Recruiting nowThis phase 3 trial tests whether acoramidis can prevent or delay transthyretin amyloidosis (ATTR) in 587 adults who carry a faulty gene but have no symptoms yet. ATTR causes sticky plaques to build up in the heart and nerves, leading to heart failure and nerve damage. Acoramidis …
Matched conditions: AMYLOID CARDIOMYOPATHY
Phase: PHASE3 • Sponsor: Eidos Therapeutics, a BridgeBio company • Aim: Prevention
Last updated Jul 01, 2026 00:00 UTC
-
Heart MRI may unlock secrets of thick heart muscle diseases
Knowledge-focused Recruiting nowThis study uses advanced heart MRI scans to look at blood flow patterns in people with different types of hypertrophic cardiomyopathy (thick heart muscle), including rare forms like Anderson-Fabry disease and cardiac amyloidosis. Researchers will also study first-degree relatives…
Matched conditions: AMYLOID CARDIOMYOPATHY
Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:01 UTC